MedTrace Logo

Learning and Executive Function Disorders in Children and Psychosis Risk at Adult-age

NCT04280367 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-08-22

No results posted yet for this study

Summary

The primary objective of the study aims to study transition toward schizophrenia in patients with learning disorders, and to compare the risk between patients with specific learning disorders, and patients with complexed learning disorders (by two types: patients with other neuro-developmental disorders including executive function disorders, and patients with anxiety).

Conditions

Interventions

DIAGNOSTIC_TEST

Standardised semi-structured talk

Comprehensive assessment of at-risk mental states (CAARMS) will be used.

DIAGNOSTIC_TEST

Autistic spectre disorder screening

Autism-spectrum quotient (AQ) auto-questionnaire will be used.

DIAGNOSTIC_TEST

Anxiety measuring

An inventory for measuring clinical anxiety: Beck Anxiety Inventory (BAI); Liebowitz Social Anxiety Scale.

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Emilie SCHLUMBERGER, MD · Centre de référence des troubles du langage et des apprentissages, Hôpital Raymond Poincaré, APHP

  • Albane Mansoux · Centre de référence des troubles du langage et des apprentissages, Hôpital Raymond Poincaré, APHP

Eligibility

Min Age
15 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-28
Primary Completion
2020-05-29
Completion
2020-05-29

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04280367 on ClinicalTrials.gov